BioCentury
ARTICLE | Emerging Company Profile

Jamming the transmission

March 29, 1999 8:00 AM UTC

With the current focus of the public equity markets on biotechnology companies that have profits from product sales, startup companies with an eye towards staying independent must convince investors that their technology will lead to products.

Message Pharmaceuticals Inc.'s SCRIBE technology has utility across a variety of diseases...